Literature DB >> 14967446

In vivo detection of an 125I seed located in the intracardiac region after prostate permanent brachytherapy.

Henry F Blair1, Arthur Porter, Qin-Sheng Chen.   

Abstract

PURPOSE: The purpose of this investigation is to determine the mechanism of seed migration after prostate implant and to develop procedures to minimize the risk of seed migration. METHODS AND MATERIALS: Radioactivity survey of prostate cancer patients after permanent brachytherapy with (125)I to detect pulmonary seed embolization is routinely performed using a seed migration detector. The seed migration detector is made from a low-energy, high-sensitivity scintillation survey meter by adding a single-hole collimation cap to the scintillation probe. If a seed migration is suspected, a pair of chest radiographs is ordered to document the location of the migrated seed. A comprehensive investigation is elicited if there are discrepancies between the seed migration detector survey and the radiographic examination.
RESULTS: One hundred five patients have been surveyed, and 20 patients have demonstrated pulmonary seed embolization. In 1 patient, the seed migration detector sensed radioactivity in the thorax, but repeat chest radiographic examinations failed to show a radiopaque foreign body in the chest cavity. Owing to the signal variation mimicking heart rate, an (125)I seed located in the intracardiac region was suspected. This suspicion was confirmed in a high-quality fluoroscopy examination.
CONCLUSIONS: Seed embolization to the intracardiac region is rarely reported. The true rate may be higher, but has not been adequately documented owing to the limitation of diagnostic quality of chest radiographs to detect seed migration to the intracardiac region. The seed migration detector, on the other hand, demonstrated its efficacy in the detection of seed migration, particularly in the detection of a seed located in the intracardiac region.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967446     DOI: 10.1016/j.ijrobp.2003.09.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Authors:  Katsumi Hirose; Masahiko Aoki; Mariko Sato; Hiroyoshi Akimoto; Yasuhiro Hashimoto; Atsushi Imai; Noritaka Kamimura; Hideo Kawaguchi; Yoshiomi Hatayama; Ichitaro Fujioka; Mitsuki Tanaka; Chikara Ohyama; Yoshihiro Takai
Journal:  Jpn J Radiol       Date:  2016-09-08       Impact factor: 2.374

2.  Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors.

Authors:  Katsuhito Miyazawa; Munetaka Matoba; Hiroshi Minato; Nobuyo Morita; Ippei Chikazawa; Kiyotaka Ota; Kosuke Tokunaga; Hisao Tonami; Takayuki Nojima; Koji Suzuki
Journal:  Jpn J Radiol       Date:  2012-07-14       Impact factor: 2.374

3.  CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy.

Authors:  Tao Zhang; Mingjian Lu; Sheng Peng; Weidong Zhang; Guang Yang; Zhenyin Liu; Sristi Singh; Yadi Yang; Fujun Zhang; Fei Gao
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-11       Impact factor: 4.553

4.  Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor.

Authors:  Ratul Mukerji; Jeffrey Schaal; Xinghai Li; Jayanta Bhattacharyya; Daisuke Asai; Michael R Zalutsky; Ashutosh Chilkoti; Wenge Liu
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

5.  Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.

Authors:  Masahiro Nakano; Atsunori Yorozu; Shiro Saito; Akitomo Sugawara; Shinichiroh Maruo; Shinsuke Kojima; Takashi Kikuchi; Masanori Fukushima; Takushi Dokiya; Hidetoshi Yamanaka
Journal:  Radiat Oncol       Date:  2015-11-14       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.